Canada Life’s Ironwood Pharmaceuticals IRWD Stock Holding History

Canada Life’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,282	Closed	-$20K	–	1970
2025 Q1	$20K	Sell	13,282 -116,225	-90%	-$277K	﹤0.01%	1936
2024 Q4	$573K	Sell	129,507 -19,003	-13%	-$77.1K	﹤0.01%	1611
2024 Q3	$611K	Sell	148,510 -32,053	-18%	-$172K	﹤0.01%	1638
2024 Q2	$1.18M	Buy	180,563 +28,071	+18%	+$199K	﹤0.01%	1467
2024 Q1	$1.33M	Buy	152,492 +5,543	+4%	+$67.3K	﹤0.01%	1419
2023 Q4	$1.68M	Sell	146,949 -102,098	-41%	-$1.01M	﹤0.01%	1324
2023 Q3	$2.4M	Sell	249,047 -35,004	-12%	-$343K	0.01%	1113
2023 Q2	$3.03M	Sell	284,051 -20,957	-7%	-$225K	0.01%	971
2023 Q1	$3.21M	Buy	305,008 +156,751	+106%	+$1.76M	0.01%	990
2022 Q4	$1.84M	Sell	148,257 -6,811	-4%	-$77.3K	﹤0.01%	1270
2022 Q3	$1.6M	Buy	155,068 +2,123	+1%	+$24.1K	﹤0.01%	1277
2022 Q2	$1.76M	Buy	152,945 +144,945	+1,812%	+$1.71M	﹤0.01%	1201
2022 Q1	$107K	Hold	8,000	–	–	﹤0.01%	1983
2021 Q4	$93K	Sell	8,000 -31,773	-80%	-$390K	﹤0.01%	2024
2021 Q3	$523K	Buy	39,773 +31,773	+397%	+$411K	﹤0.01%	1721
2021 Q2	$103K	Sell	8,000 -2,270	-22%	-$26K	﹤0.01%	2084
2021 Q1	$114K	Hold	10,270	–	–	﹤0.01%	2073
2020 Q4	$117K	Hold	10,270	–	–	﹤0.01%	2080
2020 Q3	$92K	Hold	10,270	–	–	﹤0.01%	2054
2020 Q2	$105K	Sell	10,270 -3,354	-25%	-$34.3K	﹤0.01%	2031
2020 Q1	$138K	Hold	13,624	–	–	﹤0.01%	1904
2019 Q4	$180K	Buy	+13,624	New	+$150K	﹤0.01%	1944
2019 Q3	–	Sell	-19,792	Closed	-$216K	–	1691
2019 Q2	$216K	Sell	19,792 -3,840	-16%	-$43K	﹤0.01%	2012
2019 Q1	$267K	Buy	23,632 +5,911	+33%	+$66K	﹤0.01%	1804
2018 Q4	$148K	Hold	17,721	–	–	﹤0.01%	2016
2018 Q3	$274K	Hold	17,721	–	–	﹤0.01%	1895
2018 Q2	$284K	Hold	17,721	–	–	﹤0.01%	1880
2018 Q1	$229K	Hold	17,721	–	–	﹤0.01%	1925
2017 Q4	$222K	Hold	17,721	–	–	﹤0.01%	1941
2017 Q3	$235K	Hold	17,721	–	–	﹤0.01%	1902
2017 Q2	$280K	Hold	17,721	–	–	﹤0.01%	1842
2017 Q1	$253K	Hold	17,721	–	–	﹤0.01%	1868
2016 Q4	$228K	Hold	17,721	–	–	﹤0.01%	1879
2016 Q3	$235K	Hold	17,721	–	–	﹤0.01%	1866
2016 Q2	$193K	Hold	17,721	–	–	﹤0.01%	1899
2016 Q1	$162K	Hold	17,721	–	–	﹤0.01%	1439
2015 Q4	$172K	Hold	17,721	–	–	﹤0.01%	1367
2015 Q3	$155K	Hold	17,721	–	–	﹤0.01%	1391
2015 Q2	$178K	Buy	17,721 +8,358	+89%	+$97.1K	﹤0.01%	1440
2015 Q1	$125K	Hold	9,363	–	–	﹤0.01%	1642
2014 Q4	$120K	Hold	9,363	–	–	﹤0.01%	1626
2014 Q3	$102K	Hold	9,363	–	–	﹤0.01%	1670
2014 Q2	$120K	Hold	9,363	–	–	﹤0.01%	1448
2014 Q1	$96K	Hold	9,363	–	–	﹤0.01%	1453
2013 Q4	$91K	Buy	+9,363	New	+$84K	﹤0.01%	1455

Other funds holding IRWD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Canada Life's IRWD Position: Q2 2025 in Review

Canada Life sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 13,282 shares — an estimated $20K sold.

Canada Life first reported a position in IRWD in Q4 2013 and held it in 45 quarters. The position peaked at $3.21M in Q1 2023. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

Canada Life reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Canada Life sold 13,282 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $20K.
Canada Life first reported a position in Ironwood Pharmaceuticals in Q4 2013 and held it in 45 quarters.
Canada Life's Ironwood Pharmaceuticals position peaked at $3.21M in Q1 2023.
155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on Canada Life's 13F filing for Q2 2025, filed 15 Aug 2025.